DOCSLIB.ORG

The Pcp Story

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pcp Story Narcotic Educational Foundation of America Drug Abuse Education Provider of the: California Narcotic Officers’ Association THE PCP STORY QUICK FACTS: Phencyclidine (PCP), a synthetic drug, is an illegal and mind altering drug. Phencyclidines are the single drug category which may produce signs and symptoms of several different drug categories including central nervous system depressants, central nervous system stimulants, hallucinogen, and narcotic analgesics. One or all of these symptoms may be present at some time. The presence and severity of these effects depends upon the person’s tolerance, dose, and physical makeup. Phencyclidine (PCP) exerts its primary effect by activating the region of the brain that controls mind-body disassociation or sensory deprivation. It appears to distort sensory messages sent to the central nervous system. It seems to stifle inhibitions and it deadens pain. The brain’s neurochemicals associated with phencyclidines control pain, endurance, mental stability, sleep control and self-esteem. The Phencyclidine (PCP) abuser may show classical signs of schizophrenia. The highest risk in using this drug is that there is an “unpredictability” to the outcome of the effects and the type of “trip” the user will experience. In the past there have been signs of an emotional addiction resulting in high levels of abuse in certain populations. HISTORY OF DRUG UNDER THE INFLUENCE History - (continued from column 1, this page) SIGNS AND SYMPTOMS The term PCP comes from the parent The powder can be placed with plant compound of phencyclidines named 1- material in hand rolled cigarettes and Acute confusional state of Low to phenylcyclohexyl piperidine then smoked. Medium dose: hydrochloride. The phencyclidines are PCP crystal can easily be diluted into a synthetically derived class of drugs. • Responsiveness-initially liquid. It will usually be clear to yellow The only supplies of PCP sold in the uncommunicative, may respond in color. A substance suspected to be United States are made in illegal to commands with nodding or PCP can generally be detected by its laboratories . eye movement. distinctive chemical odor. Liquid • containing PCP, when sprayed, PCP was first synthesized by Orientation - disoriented for sprinkled, or soaked onto a plant researchers at Parke Davis and time and place; appears confused or fearful; amnesia. material, which then dries, produces Company in 1956. In 1957, the first “angel dust.” The substance might be: clinical trial of the drug’s • mint leaves effectiveness as an anesthetic agent for Behavior - agitated, excited, combative, regressive, self- parsley, oregano, or other spices humans was conducted. PCP seemed marijuana to be more medically effective and destructive or bizarre. safer than other anesthetics, but • Speech - slurred, intermittently Liquid phencyclidine may also be caused other problems. When used as unable to articulate. dripped on factory cigarettes such as: a surgical anesthetic, up to thirty “Sherman “Moore” “Kool” percent of the patients manifested • Eyes - open or “blank stare agitation, excitement and appearance” with drooping of The primary method of ingestion of disorientation during the recovery eyelids, very little effect on pupil phencyclidine is by smoking the drug. period. Because of the frequency and size. The crystal or powder may be injected; severity of PCP toxic effects, it was although the practice is less common in soon limited to veterinary medicine • Nystagmus - horizontal and most geographical areas vertical. PCP Hydrochloride (HCl) in its pure The effects of PCP differ markedly with state is a powder, usually white in • Motor - gait unable to tandem dose. At low doses the most prominent color. However, due to the impurities walk, (moon) walk, muscle tone effect is similar to that of alcohol in the illicit manufacturing process it rigidity. intoxication; a generalized numbness. has a slight yellow or brownish tint to With increased doses, analgesia and then • it. This does not preclude a dealer Restlessness, repetitive anesthesia are noted. Large doses can from altering this standard appearance. movements. produce convulsions, coma or death. Most persons using PCP experience a • (Continued column 3, this page) Increased secretions-drooling. confused state characterized by feelings (Continued on page 2, column 1) History - (Continued from page 1, column 3) PHENCYCLIDINE of weightlessness, unreality, depression, RECOGNITION OF PCP METABOLISM AND anxiety and hallucinations. The inability INTOXICATION ELIMINATION to think and concentrate are often two reported findings. General Indicators: Metabolism is defined as the body’s mechanism for processing, using and The effects of PCP will vary greatly • eventually eliminating foreign depending upon the purity and amount of Perspiring heavily substances, like drugs, from the PCP used, and the individual’s • body. Once a drug has come into metabolism, sex, age, mental state, Blank stare contact with enzymes and / or psychological make-up, tolerance, etc. • chemicals in the bloodstream, a part The onset after smoking is approximately Agitation, excitement or all of the drug may take on a new 1 to 5 minutes. The drug will peak or chemical composition known as a plateau in 15 to 30 minutes and a person • Memory loss metabolite. So, as the drug exerts its will remain high for 4 - 6 hours. As much influence upon the body it is as 24-48 hours will elapse until the user • Chemical odor gradually neutralized, usually by the feels normal. liver or kidney, maybe both. • Incomplete and slurred verbal Metabolic processes generally PHARMACOLOGY OF responses decrease, but occasionally increase PHENCYCLIDINE the effects of psychoactive drugs • Increased pain threshold Since PCP is so strong, particularly for such as PCP. first time users, the range between a dose • that produces a pleasant sensory Non-communicative There are other factors that can affect deprivation effect and one that induces the metabolism of drugs: • catatonia, coma, or convulsions is very Disorientation small. Low dosages (2 to 5 mg) first Age - After the age of 30, the body • produce mild depression, then Cyclic mood swings produces fewer and fewer liver stimulation. Moderate doses (10 to 15 enzymes capable of metabolizing mg) can produce a desirable sensory- • Depersonalization certain drugs. deprived state. They can also produce extremely high blood pressure and very • Muscle rigidity Heredity - Individuals pass certain combative behavior. Other adverse traits to their offspring that affect the reactions to moderate doses include an • Hallucinations/delusions metabolism of drugs. They might inability to talk, a rigid robotic attitude, have more body fat, which will store tremors, confusion, agitation and fat-seeking type drugs like PCP. paranoid thinking. PCP is highly soluble in lipid (fat) There are three entirely different kinds of tissues. This process can allow for usage patterns noted with phencyclidine the re-release of the drug without abusers. Each carries its own respective taking in more. If the body is allowed dangers. to break down the fat into energy, One type of user smokes PCP PCP may re-enter the bloodstream. occasionally at parties, dance concerts This is often called a “PCP and other occasions. This person is least flashback.” likely to know what he or she is getting because a joint passed at a party contains Emotional State - The emotional an unknown dosage. Depending upon the state of the drug user also has a major amount used and the purity of the dose, effect on the drug action. PCP in the effect may be anything from a someone with paranoia can be very pleasant numbness to a violent freak out. dangerous because it can further disrupt the chemical balance within Another kind of user is the “regular the brain. user.” This person smokes PCP from twice a month up to three times a week. Other Drugs - The presence of Most of the regular users are hesitant to another drug can keep the body so accept the fact that they are “addicted’. busy that metabolism of a new drug Often they maintain regular employment is delayed. Poly-drug usage is not and appear to be functioning more or less LIQUID PCP only common, but develops a whole normally. IS SOMETIMES new set of medical criteria. (Continued on page #, column 1) STORED IN DARK Pharmacology - (continued from page 1) ANALOGS OF ANGEL (DEATH) DUST? PHENCYCLIDINE (PCP) “Lay off that stuff. It’s like a rattle There is a uniqueness of analogs to this class snake - it’ll kill you,” a father pleaded The third type of user is someone who with his son, Richard, whose friend uses PCP every day, or as often as it of drugs in that they have similar had died from using “that stuff.” can be found. This person is much pharmacological activity and are chemically related, but are not the same parent Richard replied, “I guess he just didn’t more likely to know what is being know how to use it.” No one else smoked because he or she is probably compound. One of the close relatives of PCP knows how to use such an dealing PCP in order to support the is a prescribed drug called Ketamine. It is used as a surgical anesthetic to control severe unpredictable drug. Richard was later expense of its use... or is buying it in found at the bottom of a swimming quantity and “doing his own thing.” pain from burns. There are reported to be at pool at his apartment complex. The So, the problems usually arise not least 34 other analogs of PCP that were looked at by Parke Davis and they all seemed newspaper reported “... curled up on from knowing what one is getting, but his side, his hands pillowed his head. rather from the fact that when to have similar pharmacological activity a to He was slumbering under water with someone uses it regularly; memory, Phencyclidine. Some of these analogs were produced by illicit laboratories to circumvent the aid of “that stuff” called Angel reasoning ability, judgment, and Dust.
Load more

Recommended publications
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • House Bill No. 325
    FIRST REGULAR SESSION HOUSE BILL NO. 325 101ST GENERAL ASSEMBLY INTRODUCED BY REPRESENTATIVE PRICE IV. 0249H.01I DANA RADEMAN MILLER, Chief Clerk AN ACT To repeal sections 195.010, 579.015, 579.020, 579.040, 579.055, and 579.105, RSMo, and to enact in lieu thereof twenty new sections relating to the legalization of marijuana for adult use, with penalty provisions. Be it enacted by the General Assembly of the state of Missouri, as follows: Section A. Sections 195.010, 579.015, 579.020, 579.040, 579.055, and 579.105, RSMo, 2 are repealed and twenty new sections enacted in lieu thereof, to be known as sections 195.010, 3 195.2300, 195.2303, 195.2309, 195.2310, 195.2312, 195.2315, 195.2317, 195.2318, 195.2321, 4 195.2324, 195.2327, 195.2330, 195.2333, 579.015, 579.020, 579.040, 579.055, 579.105, and 5 610.134, to read as follows: 195.010. The following words and phrases as used in this chapter and chapter 579, 2 unless the context otherwise requires, mean: 3 (1) "Acute pain", pain, whether resulting from disease, accidental or intentional trauma, 4 or other causes, that the practitioner reasonably expects to last only a short period of time. Acute 5 pain shall not include chronic pain, pain being treated as part of cancer care, hospice or other 6 end-of-life care, or medication-assisted treatment for substance use disorders; 7 (2) "Addict", a person who habitually uses one or more controlled substances to such an 8 extent as to create a tolerance for such drugs, and who does not have a medical need for such 9 drugs, or who is so far addicted to the use of such drugs as to have lost the power of self-control 10 with reference to his or her addiction; 11 (3) "Administer", to apply a controlled substance, whether by injection, inhalation, 12 ingestion, or any other means, directly to the body of a patient or research subject by: 13 (a) A practitioner (or, in his or her presence, by his or her authorized agent); or EXPLANATION — Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is intended to be omitted from the law.
    [Show full text]
  • “Biosynthesis of Morphine in Mammals”
    “Biosynthesis of Morphine in Mammals” D i s s e r t a t i o n zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Naturwissenschaftlichen Fakultät I Biowissenschaften der Martin-Luther-Universität Halle-Wittenberg von Frau Nadja Grobe geb. am 21.08.1981 in Querfurt Gutachter /in 1. 2. 3. Halle (Saale), Table of Contents I INTRODUCTION ........................................................................................................1 II MATERIAL & METHODS ........................................................................................ 10 1 Animal Tissue ....................................................................................................... 10 2 Chemicals and Enzymes ....................................................................................... 10 3 Bacteria and Vectors ............................................................................................ 10 4 Instruments ........................................................................................................... 11 5 Synthesis ................................................................................................................ 12 5.1 Preparation of DOPAL from Epinephrine (according to DUNCAN 1975) ................. 12 5.2 Synthesis of (R)-Norlaudanosoline*HBr ................................................................. 12 5.3 Synthesis of [7D]-Salutaridinol and [7D]-epi-Salutaridinol ..................................... 13 6 Application Experiments .....................................................................................
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years.
    [Show full text]
  • Cerebellar Toxicity of Phencyclidine
    The Journal of Neuroscience, March 1995, 75(3): 2097-2108 Cerebellar Toxicity of Phencyclidine Riitta N&kki, Jari Koistinaho, Frank Ft. Sharp, and Stephen M. Sagar Department of Neurology, University of California, and Veterans Affairs Medical Center, San Francisco, California 94121 Phencyclidine (PCP), clizocilpine maleate (MK801), and oth- Phencyclidine (PCP), dizocilpine maleate (MK801), and other er NMDA antagonists are toxic to neurons in the posterior NMDA receptor antagonistshave attracted increasing attention cingulate and retrosplenial cortex. To determine if addition- becauseof their therapeutic potential. These drugs have neuro- al neurons are damaged, the distribution of microglial ac- protective properties in animal studies of focal brain ischemia, tivation and 70 kDa heat shock protein (HSP70) induction where excitotoxicity is proposedto be an important mechanism was studied following the administration of PCP and of neuronal cell death (Dalkara et al., 1990; Martinez-Arizala et MK801 to rats. PCP (10-50 mg/kg) induced microglial ac- al., 1990). Moreover, NMDA antagonists decrease neuronal tivation and neuronal HSP70 mRNA and protein expression damage and dysfunction in other pathological conditions, in- in the posterior cingulate and retrosplenial cortex. In ad- cluding hypoglycemia (Nellgard and Wieloch, 1992) and pro- dition, coronal sections of the cerebellar vermis of PCP (50 longed seizures(Church and Lodge, 1990; Faingold et al., 1993). mg/kg) treated rats contained vertical stripes of activated However, NMDA antagonists are toxic to certain neuronal microglial in the molecular layer. In the sagittal plane, the populations in the brain. Olney et al. (1989) demonstratedthat microglial activation occurred in irregularly shaped patch- the noncompetitive NMDA antagonists,PCP, MK801, and ke- es, suggesting damage to Purkinje cells.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • MDMA, Cannabis, and Cocaine Produce Acute Dissociative Symptoms
    Psychiatry Research 228 (2015) 907–912 Contents lists available at ScienceDirect Psychiatry Research journal homepage: www.elsevier.com/locate/psychres MDMA, cannabis, and cocaine produce acute dissociative symptoms Dalena van Heugten-Van der Kloet a,b,n, Timo Giesbrecht a, Janelle van Wel a, Wendy M Bosker a,1, Kim PC Kuypers a, Eef L Theunissen a, Desirée B Spronk c,d, Robbert Jan Verkes c,d, Harald Merckelbach a, Johannes G Ramaekers a a Faculty of Psychology and Neuroscience, Maastricht University, The Netherlands b Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom c Department of Psychiatry (966), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands d Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands article info abstract Article history: Some drugs of abuse may produce dissociative symptoms, but this aspect has been understudied. We Received 4 April 2014 explored the dissociative potential of three recreational drugs (3,4-methylenedioxymethamphetamine Received in revised form (MDMA), cannabis, and cocaine) during intoxication and compared their effects to literature reports of 31 March 2015 dissociative states in various samples. Two placebo-controlled studies were conducted. In Study 1 (N¼16), Accepted 18 April 2015 participants received single doses of 25, 50, and 100 mg of MDMA, and placebo. In Study 2 (N¼21), cannabis Available online 30 April 2015 (THC 300 mg/kg), cocaine (HCl 300 mg), and placebo were administered. Dissociative symptoms as measured Keywords: with the Clinician-Administered Dissociative States Scale (CADSS) significantly increased under the influence Dissociative symptoms of MDMA and cannabis.
    [Show full text]
  • MDMA-Induced Dissociative State Not Mediated by the 5-HT2A Receptor
    fphar-08-00455 July 11, 2017 Time: 12:7 # 1 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Diposit Digital de Documents de la UAB ORIGINAL RESEARCH published: 11 July 2017 doi: 10.3389/fphar.2017.00455 MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor Drew J. Puxty1, Johannes G. Ramaekers1, Rafael de la Torre2,3,4, Magí Farré2,5,6, Neus Pizarro2,5, Mitona Pujadas2,3 and Kim P. C. Kuypers1* 1 Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands, 2 Integrative Pharmacology and Neurosciences Systems Research Group, Institut Hospital del Mar d’Investigacions Mèdiques, Barcelona, Spain, 3 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Santiago de Compostela, Spain, 4 Facultat de Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain, 5 Department of Pharmacology, Therapeutic and Toxicology, Universitat Autonoma de Barcelona, Barcelona, Spain, 6 Hospital Universitari Germans Trias i Pujol, Clinical Pharmacology, Badalona, Spain Previous research has shown that a single dose of MDMA induce a dissociative state, by elevating feelings of depersonalization and derealization. Typically, it is assumed that action on the 5-HT2A receptor is the mechanism underlying these psychedelic experiences. In addition, other studies have shown associations between dissociative states and biological parameters (heart rate, cortisol), which are elevated by MDMA. In order to investigate the role of the 5-HT2 receptor in the MDMA-induced dissociative state and the association with biological parameters, a placebo-controlled within- Edited by: subject study was conducted including a single oral dose of MDMA (75 mg), combined Andrew Robert Gallimore, with placebo or a single oral dose of the 5-HT2 receptor blocker ketanserin (40 mg).
    [Show full text]
  • From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia J
    REVIEW The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia J. David Jentsch, Ph.D., and Robert H. Roth, Ph.D. Administration of noncompetitive NMDA/glutamate effects of these drugs are discussed, especially with regard to receptor antagonists, such as phencyclidine (PCP) and differing profiles following single-dose and long-term ketamine, to humans induces a broad range of exposure. The neurochemical effects of NMDA receptor schizophrenic-like symptomatology, findings that have antagonist administration are argued to support a contributed to a hypoglutamatergic hypothesis of neurobiological hypothesis of schizophrenia, which includes schizophrenia. Moreover, a history of experimental pathophysiology within several neurotransmitter systems, investigations of the effects of these drugs in animals manifested in behavioral pathology. Future directions for suggests that NMDA receptor antagonists may model some the application of NMDA receptor antagonist models of behavioral symptoms of schizophrenia in nonhuman schizophrenia to preclinical and pathophysiological research subjects. In this review, the usefulness of PCP are offered. [Neuropsychopharmacology 20:201–225, administration as a potential animal model of schizophrenia 1999] © 1999 American College of is considered. To support the contention that NMDA Neuropsychopharmacology. Published by Elsevier receptor antagonist administration represents a viable Science Inc. model of schizophrenia, the behavioral and neurobiological KEY WORDS: Ketamine; Phencyclidine; Psychotomimetic; widely from the administration of purportedly psychot- Memory; Catecholamine; Schizophrenia; Prefrontal cortex; omimetic drugs (Snyder 1988; Javitt and Zukin 1991; Cognition; Dopamine; Glutamate Jentsch et al. 1998a), to perinatal insults (Lipska et al. Biological psychiatric research has seen the develop- 1993; El-Khodor and Boksa 1997; Moore and Grace ment of many putative animal models of schizophrenia.
    [Show full text]
  • Opioid Receptors: Structural and Mechanistic Insights Into Pharmacology and Signaling
    European Journal of Pharmacology ∎ (∎∎∎∎) ∎∎∎–∎∎∎ Contents lists available at ScienceDirect European Journal of Pharmacology journal homepage: www.elsevier.com/locate/ejphar Opioid receptors: Structural and mechanistic insights into pharmacology and signaling Yi Shang, Marta Filizola n Icahn School of Medicine at Mount Sinai, Department of Structural and Chemical Biology, One Gustave, L. Levy Place, Box 1677, New York, NY 10029, USA article info abstract Article history: Opioid receptors are important drug targets for pain management, addiction, and mood disorders. Al- Received 25 January 2015 though substantial research on these important subtypes of G protein-coupled receptors has been Received in revised form conducted over the past two decades to discover ligands with higher specificity and diminished side 2 March 2015 effects, currently used opioid therapeutics remain suboptimal. Luckily, recent advances in structural Accepted 11 May 2015 biology of opioid receptors provide unprecedented insights into opioid receptor pharmacology and signaling. We review here a few recent studies that have used the crystal structures of opioid receptors as Keywords: a basis for revealing mechanistic details of signal transduction mediated by these receptors, and for the GPCRs purpose of drug discovery. Opioid binding & 2015 Elsevier B.V. All rights reserved. Receptor Molecular dynamics Allosteric modulators Virtual screening Functional selectivity Dimerization 1. Introduction been devoted over the years to reduce the disadvantages of these drugs while retaining their therapeutic efficacy. In the absence of Opioid receptors belong to the super-family of G-protein cou- high-resolution crystal structures of opioid receptors until 2012, pled receptors (GPCRs), which are by far the most abundant class the majority of these efforts used ligand-based strategies, although of cell-surface receptors, and also the targets of about one-third of some also resorted to rudimentary molecular models of the re- approved/marketed drugs (Vortherms and Roth, 2005).
    [Show full text]
  • Hallucinogens & Dissociative Drugs
    ® DRUG FACT SHEET Hallucinogens & Dissociative Drugs Some effects of PCP including depression and memory loss may last six months to a year following prolonged daily use. Class of drug: Hallucinogens (most common form is LSD) Dissociative drugs (most commonly form is PCP) Main active ingredient: Hallucinogens: Lysergic acid diethylamide, mescaline, psilocybin, ibogaine Dissociative: Phencyclidine What it looks like: LSD: Clear, odorless liquid, brightly colored tablets, impregnated blotter paper, thin squares of gelatin PCP: liquid, capsules, white crystalline powder, gum There are hundreds of synthetic hallu - Street names: Lysergic acid diethylamide: LSD, Acid, Blotter, cinogens on the market today including Phencyclidine: PCP, Angel Dust, Loveboat, Wack 25I-NBOMe (N-Bomb) and 2C-I (Smiles) which have been attributed to How it is used: Both hallucinogens and dissociative drugs can be multiple deaths and significant injuries. swallowed, injected or smoked. LSD liquid and gelatin They are generally found as powders, liq - forms can be put in the eyes. PCP is often sprinkled uids, soaked into blotter paper or laced on or sprayed on cigarettes, parsley and marijuana. something edible. Both drugs are classi - fied as Schedule I substances, making Duration of high: Hallucinogens: effects begin within 30 to 90 minutes possession, distribution and manufacture and last from six to twelve hours illegal. PCP: effects begin within minutes and last for hours Withdrawal symptoms: Depression, memory loss U.S. information Effects: Physical (both) —increased heart rate and blood pressure, elevated body temperature, loss of In 2014, nearly 1.3 million appetite, loss of muscle coordination, slurred speech Americans aged 12 and older Hallucinogens reported using LSD in the past Mental —hallucinations; intensified senses; distortion year and 90,000 reported using of time, reality and environment; confusion; mood PCP in the past year.
    [Show full text]
  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
    Supplemental Material can be found at: /content/suppl/2020/12/18/73.1.202.DC1.html 1521-0081/73/1/202–277$35.00 https://doi.org/10.1124/pharmrev.120.000056 PHARMACOLOGICAL REVIEWS Pharmacol Rev 73:202–277, January 2021 Copyright © 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: MICHAEL NADER Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss Antonio Inserra, Danilo De Gregorio, and Gabriella Gobbi Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Quebec, Canada Abstract ...................................................................................205 Significance Statement. ..................................................................205 I. Introduction . ..............................................................................205 A. Review Outline ........................................................................205 B. Psychiatric Disorders and the Need for Novel Pharmacotherapies .......................206 C. Psychedelic Compounds as Novel Therapeutics in Psychiatry: Overview and Comparison with Current Available Treatments . .....................................206 D. Classical or Serotonergic Psychedelics versus Nonclassical Psychedelics: Definition ......208 Downloaded from E. Dissociative Anesthetics................................................................209 F. Empathogens-Entactogens . ............................................................209
    [Show full text]